MAOB and Parkinson disease: In PD trials, addition of safinamide to levodopa has demonstrated to improve both motor scores and duration of “on time” similar to other MAO-B inhibitors, with and added benefit of not increasing troublesome dyskinesia [4,5,6,7,8].